OGN
Organon & Co.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #269
- Final score
- 58.63
- Years on list
- 4
↗ Climbed 656 since 2022
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- OGN· Organon & Co.
- REGN· Regeneron Pharmaceuticals, Inc.
- ZTS· Zoetis Inc.
Figure 01 · Side-by-side summary
The headline numbers
REGN
Regeneron Pharmaceuticals, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #240
- Final score
- 59.63
- Years on list
- 6
↘ Down 124 since 2020
ZTS
Zoetis Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #271
- Final score
- 58.59
- Years on list
- 6
↗ Climbed 345 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | OGN | REGN | ZTS |
|---|---|---|---|
| Climate Change | 68.2 | 72.3 | 56.7 |
| Employee Relations | 61.8 | 54.1 | 70.6 |
| Environment | 54.1 | 59.1 | 59.0 |
| Stakeholders & Society | 58.8 | 61.1 | 50.9 |
| Human Rights | 58.1 | 41.8 | 47.9 |
| Governance | 46.5 | 55.2 | 64.9 |
| Performance Rating | 41.4 | 73.0 | 48.4 |